<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35029796</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-2576</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Inflammation</Title>
          <ISOAbbreviation>Inflammation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sigma-1 Receptor Alleviates Airway Inflammation and Airway Remodeling Through AMPK/CXCR4 Signal Pathway.</ArticleTitle>
        <Pagination>
          <StartPage>1298</StartPage>
          <EndPage>1312</EndPage>
          <MedlinePgn>1298-1312</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10753-022-01621-4</ELocationID>
        <Abstract>
          <AbstractText>Sigma non-opioid intracellular receptor 1 (Sigma-1R) has been proven to play a major role in inflammation and structural remodeling. However, its role in airway inflammation and airway remodeling remains unclear. The purpose of this study aimed to explore the role and mechanism of Sigma-1R in airway remodeling and epithelial-mesenchymal transition (EMT) process in vivo and in vitro. We observed the decrease of Sigma-1R in lung tissue of asthma model. In the mouse model of allergic airway inflammation (AAI), Sigma-1R agonist RPE-084 significantly relieved airway inflammation and airway remodeling, while Sigma-1R antagonist BD1047 (B8562) had opposite effects. Further research showed that RPE-084 treatment increased the expression of pAMPK and inhibited the expression of CXCR4. Furthermore, RPE-084 treatment suppressed the levels of IL-4, IL-5, and IL-13 in BALF. We found that RPE-084 or Sigma-1R overexpression vector treatment regulated cell cycle and inhibited cell proliferation, migration, and EMT process in TGF-β1-induced 16HBE cells. Finally, we confirmed that AMP-activated protein kinase (AMPK) inhibitor compound C or CXCR4 agonist ATI-2341 both reversed the effects of Sigma-1R on TGF-β1-induced 16 HBE cells. In a word, our research shows that Sigma-1R is helpful to improve airway remodeling of asthma, and emphasizes a new candidate molecular for asthma treatment.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Te</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Qujiang New District, Northwest Women's and Children's Hospital, No. 1616, Yanxiang Road, Xi'anShaanxi Province, 710061, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Di</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Qujiang New District, Northwest Women's and Children's Hospital, No. 1616, Yanxiang Road, Xi'anShaanxi Province, 710061, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Zhiyuan</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Interventional Radiology, Zhongshan Hospital, Fudan University and Shanghai Institute of Medical Imaging, Shanghai, 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhankui</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0003-0677-3656</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Qujiang New District, Northwest Women's and Children's Hospital, No. 1616, Yanxiang Road, Xi'anShaanxi Province, 710061, China. zhankl_1@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Inflammation</MedlineTA>
        <NlmUniqueID>7600105</NlmUniqueID>
        <ISSNLinking>0360-3997</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C514936">CXCR4 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019718">Receptors, CXCR4</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017480">Receptors, sigma</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C106106">sigma-1 receptor</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9006-59-1</RegistryNumber>
          <NameOfSubstance UI="D010047">Ovalbumin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056151" MajorTopicYN="Y">Airway Remodeling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010047" MajorTopicYN="N">Ovalbumin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019718" MajorTopicYN="N">Receptors, CXCR4</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017480" MajorTopicYN="Y">Receptors, sigma</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AMPK</Keyword>
        <Keyword MajorTopicYN="N">Airway remodeling</Keyword>
        <Keyword MajorTopicYN="N">Asthma</Keyword>
        <Keyword MajorTopicYN="N">CXCR4</Keyword>
        <Keyword MajorTopicYN="N">Sigma-1 receptor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>12</Hour>
          <Minute>20</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35029796</ArticleId>
        <ArticleId IdType="doi">10.1007/s10753-022-01621-4</ArticleId>
        <ArticleId IdType="pii">10.1007/s10753-022-01621-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Zhuang, J., H. Cui, L. Zhuang, Z. Zhai, F. Yang, G. Luo, J. He, H. Zhao, W. Zhao, Y. He, and E. Sun. 2020. Bronchial epithelial pyroptosis promotes airway inflammation in a murine model of toluene diisocyanate-induced asthma. Biomedicine &amp; Pharmacotherapy 125: 109925. https://doi.org/10.1016/j.biopha.2020.109925 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2020.109925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang, I.V., and D.A. Schwartz. 2012. Epigenetic mechanisms and the development of asthma. The Journal of Allergy and Clinical Immunology 130 (6): 1243–1255. https://doi.org/10.1016/j.jaci.2012.07.052 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2012.07.052</ArticleId>
            <ArticleId IdType="pubmed">23026498</ArticleId>
            <ArticleId IdType="pmc">3518374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kabesch, M., S. Michel, and J. Tost. 2010. Epigenetic mechanisms and the relationship to childhood asthma. European Respiratory Journal 36 (4): 950–961. https://doi.org/10.1183/09031936.00019310 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00019310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaminska, M., S. Foley, K. Maghni, C. Storness-Bliss, H. Coxson, H. Ghezzo, C. Lemière, R. Olivenstein, P. Ernst, Q. Hamid, and J. Martin. 2009. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. Journal of Allergy and Clinical Immunology 124 (1): 45–51.e41–44. https://doi.org/10.1016/j.jaci.2009.03.049</Citation>
        </Reference>
        <Reference>
          <Citation>Liu, F., and Y.X. Shang. 2020. Sirtuin 6 attenuates epithelial-mesenchymal transition by suppressing the TGF-β1/Smad3 pathway and c-Jun in asthma models. International Immunopharmacology 82: 106333. https://doi.org/10.1016/j.intimp.2020.106333 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2020.106333</ArticleId>
            <ArticleId IdType="pubmed">32143002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster, P.S., S. Maltby, H.F. Rosenberg, H.L. Tay, S.P. Hogan, A.M. Collison, M. Yang, G.E. Kaiko, P.M. Hansbro, R.K. Kumar, and J. Mattes. 2017. Modeling T(H) 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma. Immunological Reviews 278 (1): 20–40. https://doi.org/10.1111/imr.12549 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imr.12549</ArticleId>
            <ArticleId IdType="pubmed">28658543</ArticleId>
            <ArticleId IdType="pmc">5492958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall, A.A., Y. Herrera, C.T. Ajmo Jr., J. Cuevas, and K.R. Pennypacker. 2009. Sigma receptors suppress multiple aspects of microglial activation. Glia 57 (7): 744–754. https://doi.org/10.1002/glia.20802 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.20802</ArticleId>
            <ArticleId IdType="pubmed">19031439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moritz, C., F. Berardi, C. Abate, and F. Peri. 2015. Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries. Neuroscience Letters 591: 13–18. https://doi.org/10.1016/j.neulet.2015.02.004 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2015.02.004</ArticleId>
            <ArticleId IdType="pubmed">25666889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tesei, A., M. Cortesi, S. Pignatta, C. Arienti, G.M. Dondio, C. Bigogno, A. Malacrida, M. Miloso, C. Meregalli, A. Chiorazzi, V. Carozzi, G. Cavaletti, M. Rui, A. Marra, D. Rossi, and S. Collina. 2019. Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer. Frontier in Pharmacology 10: 490. https://doi.org/10.3389/fphar.2019.00490 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2019.00490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppler, and P.E. Gilbert. 1976. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. Journal of Pharmacology and Experimental Therapeutics 197 (3): 517–532.</Citation>
        </Reference>
        <Reference>
          <Citation>Hanner, M., F.F. Moebius, A. Flandorfer, H.G. Knaus, J. Striessnig, E. Kempner, and H. Glossmann. 1996. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proceedings of the National Academy of Sciences USA 93 (15): 8072–8077. https://doi.org/10.1073/pnas.93.15.8072 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.93.15.8072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colabufo, N.A., F. Berardi, M. Contino, F. Fazio, M. Matarrese, R.M. Moresco, M. Niso, R. Perrone, and V. Tortorella. 2005. Distribution of sigma receptors in EMT-6 cells: Preliminary biological evaluation of PB167 and potential for in-vivo PET. Journal of Pharmacy and Pharmacology 57 (11): 1453–1459. https://doi.org/10.1211/jpp.57.11.0011 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1211/jpp.57.11.0011</ArticleId>
            <ArticleId IdType="pubmed">16259778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aydar, E., C. Palmer, V. Klyachko, and M.J.N. Jackson. 2002. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. 34 (3): 399–410. https://doi.org/10.1016/s0896-6273(02)00677-3 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0896-6273(02)00677-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang, X., L. Liu, S. Jiang, Y. Zhong, and X.Y.N. Yang. 2011. Activation of the ζ receptor 1 suppresses NMDA responses in rat retinal ganglion cells. Neuroscience 177: 12–22. https://doi.org/10.1016/j.neuroscience.2010.12.064 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2010.12.064</ArticleId>
            <ArticleId IdType="pubmed">21211548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang, H., and J. Cuevas. 2005. σ Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons. Journal of Pharmacology and Experimental Therapeutics 313 (3): 1387–1396. https://doi.org/10.1124/jpet.105.084152 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/jpet.105.084152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen, X., C. Zhang, Y. Guo, X. Liu, T. Ye, Y. Fo, C. Qu, J. Liang, S. Shi, and B. Yang. 2020. Chronic stimulation of the sigma-1 receptor ameliorates ventricular ionic and structural remodeling in a rodent model of depression. Life Sciences 257: 118047. https://doi.org/10.1016/j.lfs.2020.118047 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2020.118047</ArticleId>
            <ArticleId IdType="pubmed">32629001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye, T., X. Liu, C. Qu, C. Zhang, Y. Fo, Y. Guo, X. Chen, S. Shi, and B. Yang. 2019. Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling. Life Sciences 235: 116837. https://doi.org/10.1016/j.lfs.2019.116837 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2019.116837</ArticleId>
            <ArticleId IdType="pubmed">31493481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen, X., C. Zhang, Y. Guo, X. Liu, T. Ye, Y. Fo, C. Qu, J. Liang, S. Shi, and B. Yang. 2020. Chronic stimulation of the sigma-1 receptor ameliorates ventricular ionic and structural remodeling in a rodent model of depression. Life Sciences 257: 118047. https://doi.org/10.1016/j.lfs.2020.118047 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2020.118047</ArticleId>
            <ArticleId IdType="pubmed">32629001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye, T., X. Liu, C. Qu, C. Zhang, Y. Fo, Y. Guo, X. Chen, S. Shi, and B. Yang. 2019. Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling. Life Sciences 235: 116837. https://doi.org/10.1016/j.lfs.2019.116837 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2019.116837</ArticleId>
            <ArticleId IdType="pubmed">31493481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carcolé, M., S. Kummer, L. Gonçalves, D. Zamanillo, M. Merlos, A. Dickenson, B. Fernández-Pastor, D. Cabañero, and R. Maldonado. 2019. Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain. British Journal of Pharmacology 176 (20): 3939–3955. https://doi.org/10.1111/bph.14794 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bph.14794</ArticleId>
            <ArticleId IdType="pubmed">31332781</ArticleId>
            <ArticleId IdType="pmc">6811737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen D.A., S.M. Seki, A. Fernández-Castañeda, R.M. Beiter, J.D. Eccles, J.A. Woodfolk, and  A. Gaultier. 2019. Erratum for the Research Article: “Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis” by D.A. Rosen, S.M. Seki, A. Fernández-Castañeda, R.M. Beiter, J.D. Eccles, J.A. Woodfolk, A. Gaultier. Science Translational Medicine 11 (485). https://doi.org/10.1126/scitranslmed.aax3130</Citation>
        </Reference>
        <Reference>
          <Citation>Ijaz, T., K. Pazdrak, M. Kalita, R. Konig, S. Choudhary, B. Tian, I. Boldogh, and A.R. Brasier. 2014. Systems biology approaches to understanding Epithelial Mesenchymal Transition (EMT) in mucosal remodeling and signaling in asthma. World Allergy Organization Journal 7 (1): 13. https://doi.org/10.1186/1939-4551-7-13 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1939-4551-7-13</ArticleId>
            <ArticleId IdType="pmc">4068075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakin, A., A. Tomlinson, N. Bhowmick, H. Moses, and C.L. Arteaga. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. Journal of Biological Chemistry 275 (47): 36803–36810. https://doi.org/10.1074/jbc.M005912200 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M005912200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Mutius, E. 2004. Influences in allergy: epidemiology and the environment. Journal of Allergy and Clinical Immunology 113 (3): 373–379; quiz 380. https://doi.org/10.1016/j.jaci.2003.12.040</Citation>
        </Reference>
        <Reference>
          <Citation>Doerner, A.M., and B.L. Zuraw. 2009. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respiratory Research 10 (1): 100. https://doi.org/10.1186/1465-9921-10-100 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1465-9921-10-100</ArticleId>
            <ArticleId IdType="pubmed">19857272</ArticleId>
            <ArticleId IdType="pmc">2774671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>GBD. 2017. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. Respiratory Medicine 5 (9): 691–706. https://doi.org/10.1016/s2213-2600(17)30293-x</Citation>
        </Reference>
        <Reference>
          <Citation>To, T., S. Stanojevic, G. Moores, A.S. Gershon, E.D. Bateman, A.A. Cruz, and L.P. Boulet. 2012. Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health 12: 204. https://doi.org/10.1186/1471-2458-12-204 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2458-12-204</ArticleId>
            <ArticleId IdType="pubmed">22429515</ArticleId>
            <ArticleId IdType="pmc">3353191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loerbroks, A., J.A. Bosch, A. Sheikh, S. Yamamoto, and R.M. Herr. 2018. Reports of wheezing and of diagnosed asthma are associated with impaired social functioning: Secondary analysis of the cross-sectional World Health Survey data. Journal of Psychosomatic Research 105: 52–57. https://doi.org/10.1016/j.jpsychores.2017.12.008 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpsychores.2017.12.008</ArticleId>
            <ArticleId IdType="pubmed">29332634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao, L., S. Wang, P. Wei, K. Bao, W. Yuan, X. Wang, J. Zheng, and M. Hong. 2019. Huangqi-Fangfeng protects against allergic airway remodeling through inhibiting epithelial-mesenchymal transition process in mice via regulating epithelial derived TGF-β1. Phytomedicine 64: 153076. https://doi.org/10.1016/j.phymed.2019.153076 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phymed.2019.153076</ArticleId>
            <ArticleId IdType="pubmed">31473579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yadav, U.C., A.S. Naura, L. Aguilera-Aguirre, I. Boldogh, H.A. Boulares, W.J. Calhoun, K.V. Ramana, and S.K. Srivastava. 2013. Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3Œ? pathway in mice. PLoS One 8 (2): e57442. https://doi.org/10.1371/journal.pone.0057442 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0057442</ArticleId>
            <ArticleId IdType="pubmed">23460857</ArticleId>
            <ArticleId IdType="pmc">3584054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam, and D.P. Taylor. 1992. A proposal for the classification of sigma binding sites. Trends in Pharmacological Sciences 13 (3): 85–86. https://doi.org/10.1016/0165-6147(92)90030-a .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0165-6147(92)90030-a</ArticleId>
            <ArticleId IdType="pubmed">1315463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hellewell, S.B., and W.D. Bowen. 1990. A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Research 527 (2): 244–253. https://doi.org/10.1016/0006-8993(90)91143-5 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(90)91143-5</ArticleId>
            <ArticleId IdType="pubmed">2174717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hellewell, S.B., A. Bruce, G. Feinstein, J. Orringer, W. Williams, and W.D. Bowen. 1994. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: Characterization by ligand binding and photoaffinity labeling. European Journal of Pharmacology 268 (1): 9–18. https://doi.org/10.1016/0922-4106(94)90115-5 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0922-4106(94)90115-5</ArticleId>
            <ArticleId IdType="pubmed">7925616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penke, B., L. Fulop, M. Szucs, and E. Frecska. 2018. The role of Sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases. Current Neuropharmacology 16 (1): 97–116. https://doi.org/10.2174/1570159x15666170529104323 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1570159x15666170529104323</ArticleId>
            <ArticleId IdType="pubmed">28554311</ArticleId>
            <ArticleId IdType="pmc">5771390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moebius, F.F., R.J. Reiter, M. Hanner, and H. Glossmann. 1997. High affinity of sigma 1-binding sites for sterol isomerization inhibitors: Evidence for a pharmacological relationship with the yeast sterol C8–C7 isomerase. British Journal of Pharmacology 121 (1): 1–6. https://doi.org/10.1038/sj.bjp.0701079 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0701079</ArticleId>
            <ArticleId IdType="pubmed">9146879</ArticleId>
            <ArticleId IdType="pmc">1564641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayashi, T. 2019. The Sigma-1 receptor in cellular stress signaling. Frontiers in Neuroscience 13: 733. https://doi.org/10.3389/fnins.2019.00733 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2019.00733</ArticleId>
            <ArticleId IdType="pubmed">31379486</ArticleId>
            <ArticleId IdType="pmc">6646578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai, S.Y., M.J. Pokrass, N.R. Klauer, N.E. De Credico, and T.P. Su. 2014. Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders. Expert Opinion on Therapeutic Targets 18 (12): 1461–1476. https://doi.org/10.1517/14728222.2014.972939 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14728222.2014.972939</ArticleId>
            <ArticleId IdType="pubmed">25331742</ArticleId>
            <ArticleId IdType="pmc">5518923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu, Z., L. Li, L.T. Zheng, Z. Xu, L. Guo, and X. Zhen. 2015. Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation. Journal of Neurochemistry 134 (5): 904–914. https://doi.org/10.1111/jnc.13182 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.13182</ArticleId>
            <ArticleId IdType="pubmed">26031312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang, Q., Y. Cui, X. Wu, and J. Wang. 2021. Evodiamine protects against airway remodelling and inflammation in asthmatic rats by modulating the HMGB1/NF-κB/TLR-4 signalling pathway. Pharmaceutical Biology 59 (1): 192–199. https://doi.org/10.1080/13880209.2020.1871374 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13880209.2020.1871374</ArticleId>
            <ArticleId IdType="pubmed">33577738</ArticleId>
            <ArticleId IdType="pmc">7889089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baulida, J. 2017. Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts. Molecular Oncology 11 (7): 847–859. https://doi.org/10.1002/1878-0261.12080 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1878-0261.12080</ArticleId>
            <ArticleId IdType="pubmed">28544627</ArticleId>
            <ArticleId IdType="pmc">5496490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hackett, T.L., S.M. Warner, D. Stefanowicz, F. Shaheen, D.V. Pechkovsky, L.A. Murray, R. Argentieri, A. Kicic, S.M. Stick, T.R. Bai, and D.A. Knight. 2009. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. American Journal of Respiratory and Critical Care Medicine 180 (2): 122–133. https://doi.org/10.1164/rccm.200811-1730OC .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200811-1730OC</ArticleId>
            <ArticleId IdType="pubmed">19406982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang, Z.C., M.J. Yi, N. Ran, C. Wang, P. Fu, X.Y. Feng, L. Xu, and Z.H. Qu. 2013. Transforming growth factor-β1 induces bronchial epithelial cells to mesenchymal transition by activating the Snail pathway and promotes airway remodeling in asthma. Molecular Medicine Reports 8 (6): 1663–1668. https://doi.org/10.3892/mmr.2013.1728 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2013.1728</ArticleId>
            <ArticleId IdType="pubmed">24126595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson, J.R., M. Nishioka, J. Chakir, P.A. Risse, I. Almaghlouth, A.N. Bazarbashi, S. Plante, J.G. Martin, D. Eidelman, and Q. Hamid. 2013. IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respiratory Research 14 (1): 118. https://doi.org/10.1186/1465-9921-14-118 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1465-9921-14-118</ArticleId>
            <ArticleId IdType="pubmed">24283210</ArticleId>
            <ArticleId IdType="pmc">4176096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loffredo, L.F., H. Abdala-Valencia, K.R. Anekalla, L. Cuervo-Pardo, C.J. Gottardi, and S. Berdnikovs. 2017. Beyond epithelial-to-mesenchymal transition: Common suppression of differentiation programs underlies epithelial barrier dysfunction in mild, moderate, and severe asthma. Allergy 72 (12): 1988–2004. https://doi.org/10.1111/all.13222 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/all.13222</ArticleId>
            <ArticleId IdType="pubmed">28599074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun, Q., J. Fan, T.R. Billiar, and M.J. Scott. 2017. Inflammasome and autophagy regulation – a two-way street. Molecular Medicine 23: 188–195. https://doi.org/10.2119/molmed.2017.00077 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2119/molmed.2017.00077</ArticleId>
            <ArticleId IdType="pubmed">28741645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalluri, R., and R.A. Weinberg. 2009. The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation 119 (6): 1420–1428. https://doi.org/10.1172/jci39104 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/jci39104</ArticleId>
            <ArticleId IdType="pubmed">19487818</ArticleId>
            <ArticleId IdType="pmc">2689101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi, K., K. Koyama, M. Suzukawa, S. Igarashi, A. Hebisawa, T. Nagase, and K. Ohta. 2016. Epithelial-mesenchymal transition promotes reactivity of human lung adenocarcinoma A549 cells to CpG ODN. Allergology International 65 (Suppl): S45-52. https://doi.org/10.1016/j.alit.2016.06.010 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.alit.2016.06.010</ArticleId>
            <ArticleId IdType="pubmed">27475623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hackett, T.L. 2012. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Current opinion in Allergy and Clinical Immunology 12 (1): 53–59. https://doi.org/10.1097/ACI.0b013e32834ec6eb .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/ACI.0b013e32834ec6eb</ArticleId>
            <ArticleId IdType="pubmed">22217512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie, D.G. 2007. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nature Reviews Molecular Cell Biology 8 (10): 774–785. https://doi.org/10.1038/nrm2249 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm2249</ArticleId>
            <ArticleId IdType="pubmed">17712357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim, J., M. Kundu, B. Viollet, and K.L. Guan. 2011. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 13 (2): 132–141. https://doi.org/10.1038/ncb2152 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb2152</ArticleId>
            <ArticleId IdType="pubmed">21258367</ArticleId>
            <ArticleId IdType="pmc">3987946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie, D.G., F.A. Ross, and S.A. Hawley. 2012. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology 13 (4): 251–262. https://doi.org/10.1038/nrm3311 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3311</ArticleId>
            <ArticleId IdType="pubmed">22436748</ArticleId>
            <ArticleId IdType="pmc">5726489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang, Y., W. Huang, J. Wang, Z. Xu, J. He, X. Lin, Z. Zhou, and J. Zhang. 2014. Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy. International Journal of Biological Sciences 10 (3): 268–277. https://doi.org/10.7150/ijbs.7929 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijbs.7929</ArticleId>
            <ArticleId IdType="pubmed">24644425</ArticleId>
            <ArticleId IdType="pmc">3957082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie, D.G. 2011. AMP-activated protein kinase: An energy sensor that regulates all aspects of cell function. Genes &amp; Development 25 (18): 1895–1908. https://doi.org/10.1101/gad.17420111 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.17420111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salt, I., and T.M. Palmer. 2012. Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opinion on Investigational Drugs 21 (8): 1155–1167. https://doi.org/10.1517/13543784.2012.696609 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/13543784.2012.696609</ArticleId>
            <ArticleId IdType="pubmed">22694351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee, J.S., S.J. Park, Y.S. Cho, J.W. Huh, Y.M. Oh, and S.D. Lee. 2015. Role of AMP-activated protein kinase (AMPK) in smoking-induced lung inflammation and emphysema. Tuberculosis and Respiratory Diseases (Seoul) 78 (1): 8–17. https://doi.org/10.4046/trd.2015.78.1.8 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4046/trd.2015.78.1.8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan, Y., L. Liu, S. Li, K. Wang, R. Ke, W. Shi, J. Wang, X. Yan, Q. Zhang, Q. Wang, L. Chai, X. Xie, and M. Li. 2018. Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms. Science and Reports 8 (1): 3624. https://doi.org/10.1038/s41598-018-21812-0 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-21812-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mancuso, R., J. Del Valle, M. Morell, M. Pallás, R. Osta, and X. Navarro. 2014. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: overlapping effects or limited therapeutic opportunity? Orphanet Journal of Rare Diseases 9: 78. https://doi.org/10.1186/1750-1172-9-78 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1172-9-78</ArticleId>
            <ArticleId IdType="pubmed">24885036</ArticleId>
            <ArticleId IdType="pmc">4035830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra, R., B.L. Cool, K.R. Laderoute, M. Foretz, B. Viollet, and M.S. Simonson. 2008. AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. Journal of Biological Chemistry 283 (16): 10461–10469. https://doi.org/10.1074/jbc.M800902200 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M800902200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin, H.S., J. Ko, D.A. Kim, E.S. Ryu, H.M. Ryu, S.H. Park, Y.L. Kim, E.S. Oh, and D.H. Kang. 2017. Metformin ameliorates the phenotype transition of peritoneal mesothelial cells and peritoneal fibrosis via a modulation of oxidative stress. Science and Reports 7 (1): 5690. https://doi.org/10.1038/s41598-017-05836-6 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-05836-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth, M.D., K.M. Whittaker, R. Choi, D.P. Tashkin, and G.C. Baldwin. 2005. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. Journal of Leukocyte Biology 78 (6): 1198–1203. https://doi.org/10.1189/jlb.0405219 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0405219</ArticleId>
            <ArticleId IdType="pubmed">16204638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin, H., Y. Wang, W. Chen, S. Zhong, Z. Liu, and J. Zhao. 2016. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC. Gene 594 (1): 23–29. https://doi.org/10.1016/j.gene.2016.08.043 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gene.2016.08.043</ArticleId>
            <ArticleId IdType="pubmed">27581786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen, H., X. Xu, J. Teng, S. Cheng, H. Bunjhoo, Y. Cao, J. Liu, J. Xie, C. Wang, Y. Xu, and W. Xiong. 2016. CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response. Experimental and Therapeutic Medicine 11 (5): 1865–1870. https://doi.org/10.3892/etm.2016.3141 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2016.3141</ArticleId>
            <ArticleId IdType="pubmed">27168818</ArticleId>
            <ArticleId IdType="pmc">4840799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia, Y., G. Shan, H. Yang, J. Zha, L. Wang, J. Chen, and X. Zhang. 2021. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling. Chemico-biological interactions 339: 109424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cbi.2021.109424</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
